Senior insider sale
CHIEF FINANCIAL OFFICER at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$464.3K
10.82K shares
What this filing means
CLINE CHRISTOPHER R. plans to sell 10.82K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $464.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/6/2026ACC: 0001950047-26-004102
Officer· CHIEF FINANCIAL OFFICER
Since Feb 2026
10.82K
Shares to sell
$464.3K
Approx. market value
310.00
Acquired (3 months)
1
Planned
5 completed
Securities Acquired — Last 3 Months1
Performance Shares
Not Applicable
5/4/2026
310.00Total acquired310.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/4/2026 | Performance Shares Not Applicable | 310.00 | — |
| Total | 310.00 | ||
Planned & Completed Dispositions6
Completed
—Completed
Units to sell
2.18K
Market value
$101.7K
5/5/2026
—Completed
Units to sell
1.01K
Market value
$43.2K
4/15/2026
—Completed
Units to sell
9.00
Market value
$369.63
4/14/2026
—Completed
Units to sell
7.24K
Market value
$303.5K
4/14/2026
—Completed
Units to sell
65.00
Market value
$1.9K
4/13/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
310.00
Market value
$13.6K
5/6/2026
Total
Units
10.82K
Value
$464.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/5/2026 | 2.18K | $101.7K | — | Completed |
4/15/2026 | 1.01K | $43.2K | — | Completed |
4/14/2026 | 9.00 | $369.63 | — | Completed |
4/14/2026 | 7.24K | $303.5K | — | Completed |
4/13/2026 | 65.00 | $1.9K | — | Completed |
| Planned — Approximate Date | ||||
5/6/2026 | 310.00 | $13.6K | NASDAQ | Planned |
| Total | 10.82K | $464.3K | ||